David Uffer

Managing Director, MedTech
Trinity Life Sciences

​

David Uffer is a 30+ year seasoned executive having a career dedicated to the Medtech industry. He currently serves as the Managing Director of MedTech at Trinity Life Sciences, a 1200 person global management and strategy consulting firm. He also serves as an advisor to a $5B Family Office in healthcare investing. Prior to Trinity, David was the VP, Medtech of General Inception where he led company formation, venture investments and the portfolio in early stage companies. Prior to General Inception David was the Senior Partner and VP of Medtech at a global consulting and investment banking firm. 
In his previous 25 years in corporate roles David led Business Development for a $5B division of Medtronic (legacy Covidien) in their respiratory, monitoring and med/surg products. He ran deals in M&A, distribution, co-development and also executed minority equity investments in companies of strategic interest. Prior to Medtronic, David was Director of Corporate Development at Hologic developing company strategy and executing deals across gyn surgery, breast health, and molecular diagnostics.
David also has managed Boston Scientific’s strategy and business development function in vascular surgery, interventional medicine and oncology. He has held management roles at Integra Lifesciences directing neuromonitoring and neurosurgery business units. David initiated his career with Abbott Labs in their global business intelligence function. During his tenure across each of these roles David has screened, diligence and advised over 15,000 medical technologies. He has served on 8 Board of Directors and Board of Advisors across various stages of company development and commercial growth.

​​
 

Speech title & Synopsis

Panel Discussion 3: MedTech & Diagnosis

as panelist